One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Persistent challenges following percutaneous interventions: paravalvular regurgitation, in-stent restenosis, and antiplatelet treatment-related bleeding
Filippo Crea
doi : 10.1093/eurheartj/ehad212
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1287–1290
Managing mental well-being and the emotional aspects of cardiovascular disease: views from the patient lounge
Paul McGreavy
doi : 10.1093/eurheartj/ehac609
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1291–1292
Unravelling associations between maternal health and congenital heart defect risk in the offspring—the FINNPEDHEART study
Anu Kaskinen, Emmi Helle
doi : 10.1093/eurheartj/ehad033
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1293–1295
Obituary for Frank Marcus, outstanding medical scientist of right ventricular dysplasia/cardiomyopathy
Gaetano Thiene, Gianfranco Buja, Barbara Bauce, Domenico Corrado, Cristina Basso, Jeffrey Saffitz
doi : 10.1093/eurheartj/ehad038
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1296–1298
Aspirin for venous thromboprophylaxis after fracture: ready for prime time?
Rocco Vergallo, Carlo Patrono
doi : 10.1093/eurheartj/ehad098
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1299–1300
Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statement
Gill Louise Buchanan, Valeria Paradies, Nicole Karam, Lene Holmvang, Mamas A Mamas, Julinda Mehilli, Davide Capodanno, Piera Capranzano, Yolande Appelman, Stéphane Manzo-Silberman, Vijay Kunadian, Josepa Mauri, Stefanie Shuepke, Anna Sonia Petronio, Marta Kaluzna-Oleksy, Martine Gilard, Marie Claude Morice, Emanuele Barbato, Dariusz Dudek, Alaide Chieffo
doi : 10.1093/eurheartj/ehad053
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1301–1312
Despite the increasing proportion of female medical and nursing students, there is still a significant under-representation of women working as healthcare providers in interventional cardiology, with very few of them reaching senior leadership, academic positions, or acting principal investigators, as well as actively involved in company advisory boards. In this position paper, we will describe the current status of women working in interventional cardiology across Europe.
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Emanuele Barbato, MD, PhD, Michel Azizi, MD, Roland E Schmieder, MD, Lucas Lauder, MD, Michael Böhm, MD, Sofie Brouwers, MD, PhD, Rosa Maria Bruno, MD, PhD, Dariusz Dudek, MD, PhD, Thomas Kahan, MD, PhD, David E Kandzari, MD, Thomas F Lüscher, MD, Gianfranco Parati, MD, Atul Pathak, MD, PhD, Flavio L Ribichini, MD, Markus P Schlaich, MD, Andrew S P Sharp, MD, Isabella Sudano, MD, PhD, Massimo Volpe, MD, Costas Tsioufis, MD, William Wijns, MD, PhD, Felix Mahfoud, MD, MA
doi : 10.1093/eurheartj/ehad054
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1313–1330
Since the publication of the 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several high-quality studies, including randomised, sham-controlled trials on catheter-based renal denervation (RDN) were published, confirming both the blood pressure (BP)-lowering efficacy and safety of radiofrequency and ultrasound RDN in a broad range of patients with hypertension, including resistant hypertension.
Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications
Uri Landes, Aviram Hochstadt, Lisa Manevich, John G Webb, Janarthanan Sathananthan, Horst Sievert, Kerstin Piayda, Martin B Leon, Tamim M Nazif, David Blusztein, David Hildick-Smith, Chris Pavitt, Holger Thiele, Mohamed Abdel-Wahab, Nicolas M Van Mieghem, Rik Adrichem, Lars Sondergaard, Ole De Backer, Raj R Makkar, Ofir Koren, Thomas Pilgrim, Taishi Okuno, Ran Kornowski, Pablo Codner, Ariel Finkelstein, Itamar Loewenstein, Israel Barbash, Amir Sharon, Federico De Marco, Matteo Montorfano, Nicola Buzzatti, Azeem Latib, Andrea Scotti, Won-Keun Kim, Christian Hamm, Luis Nombela Franco, Antonio Mangieri, Wolfgang H Schoels, Marco Barbanti, Matjaz Bunc, Myriama Akodad, Ronen Rubinshtein, Haim Danenberg
doi : 10.1093/eurheartj/ehad146
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1331–1339
Paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is associated with increased morbidity and mortality. The effect of transcatheter interventions to treat PVR after the index TAVI was investigated.
Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation
Christine J Chung, Catherine M Otto
doi : 10.1093/eurheartj/ehad151
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1340–1342
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial
Daniele Giacoppo, Hector A Alvarez-Covarrubias, Tobias Koch, Salvatore Cassese, Erion Xhepa, Thorsten Kessler, Jens Wiebe, Michael Joner, Willibald Hochholzer, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati, Sebastian Kufner
doi : 10.1093/eurheartj/ehad026
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1343–1357
The best interventional strategy for the treatment of drug-eluting stent (DES) in-stent restenosis (ISR) is still unclear and no data from randomized trials beyond 3-year follow-up are available. We aimed to define 10-year comparative efficacy and safety of plain balloon (PB), paclitaxel-coated balloon (PCB), and paclitaxel-eluting stent (PES) for percutaneous coronary intervention (PCI) of DES-ISR.
Drug-coated balloons: from treatment of in-stent restenosis to extended indications. What’s next?
Domitilla Gentile, Mario Iannaccone, Alaide Chieffo
doi : 10.1093/eurheartj/ehad042
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1357–1359
Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis
Jeehoon Kang, Konstantinos D Rizas, Kyung Woo Park, Jaewook Chung, Wout van den Broek, Daniel M F Claassens, Eun ho Choo, Dániel Aradi, Steffen Massberg, Doyeon Hwang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Kiyuk Chang, Jur M ten Berg, Dirk Sibbing, Bon-Kwon Koo, Hyo-Soo Kim
doi : 10.1093/eurheartj/ehac829
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1360–1370
Dual-antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 inhibitor is the standard treatment for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).
P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes
Gjin Ndrepepa, Adnan Kastrati
doi : 10.1093/eurheartj/ehad050
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1371–1373
Prednisone for inflammatory cardiomyopathy: more than just an immunosuppressive agent
Zhiqiang Yang, Yue Li, Chao Liu
doi : 10.1093/eurheartj/ehad068
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1374–1375
Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions
Andrea Frustaci, Matteo Antonio Russo, Cristina Chimenti
doi : 10.1093/eurheartj/ehad069
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Page 1376
One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation
Jinmiao Chen, Ye Yang, Lai Wei
doi : 10.1093/eurheartj/ehad094
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Page 1377
Successful aspiration of an iatrogenic clot in transit secondary to a failed mechanical thrombectomy in pulmonary embolism
David Chipayo-Gonzales, Pablo Salinas, Ana Viana-Tejedor
doi : 10.1093/eurheartj/ehad095
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Page 1378
Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
doi : 10.1093/eurheartj/ehad005
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Page 1312
Corrigendum to: Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction
doi : 10.1093/eurheartj/ehad045
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Page 1330
